These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25201169)

  • 1. A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales.
    Hyland ME; Whalley B; Jones RC; Masoli M
    Qual Life Res; 2015 Mar; 24(3):631-9. PubMed ID: 25201169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.
    Norman G; Faria R; Paton F; Llewellyn A; Fox D; Palmer S; Clifton I; Paton J; Woolacott N; McKenna C
    Health Technol Assess; 2013 Nov; 17(52):1-342. PubMed ID: 24267198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe asthma is related to high societal costs and decreased health related quality of life.
    Jansson SA; Backman H; Andersson M; Telg G; Lindberg A; Stridsman C; Lundbäck B; Rönmark E
    Respir Med; 2020 Feb; 162():105860. PubMed ID: 32056670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma.
    Al Efraij K; Johnson KM; Wiebe D; Sadatsafavi M; FitzGerald JM
    J Asthma; 2019 Dec; 56(12):1334-1346. PubMed ID: 30513226
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients.
    Siergiejko Z; Świebocka E; Smith N; Peckitt C; Leo J; Peachey G; Maykut R
    Curr Med Res Opin; 2011 Nov; 27(11):2223-8. PubMed ID: 21933100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient characteristics and eligibility for biologics in severe asthma: Results from the Greek cohort of the RECOGNISE "real world" study.
    Bakakos P; Tryfon S; Palamidas A; Mathioudakis N; Galanakis P
    Respir Med; 2023; 210():107170. PubMed ID: 36841360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies.
    Chalitsios CV; Shaw DE; McKeever TM
    Thorax; 2021 Jan; 76(1):21-28. PubMed ID: 33087546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma.
    Sher LD; Passalacqua G; Taillé C; Cohn L; Daizadeh N; Pandit-Abid N; Soler X; Khodzhayev A; Jacob-Nara JA; Deniz Y; Rowe PJ; Nag A; Zhang Y
    Ann Allergy Asthma Immunol; 2023 Mar; 130(3):298-304. PubMed ID: 36509407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma.
    Hyland ME; Lanario JW; Pooler J; Masoli M; Jones RC
    Health Qual Life Outcomes; 2018 Jan; 16(1):24. PubMed ID: 29374455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
    Wechsler ME; Colice G; Griffiths JM; Almqvist G; Skärby T; Piechowiak T; Kaur P; Bowen K; Hellqvist Å; Mo M; Garcia Gil E
    Respir Res; 2020 Oct; 21(1):264. PubMed ID: 33050928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral corticosteroid exposure and adverse effects in asthmatic patients.
    Sullivan PW; Ghushchyan VH; Globe G; Schatz M
    J Allergy Clin Immunol; 2018 Jan; 141(1):110-116.e7. PubMed ID: 28456623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways.
    Cataldo D; Louis R; Michils A; Peché R; Pilette C; Schleich F; Ninane V; Hanon S
    J Asthma; 2021 Apr; 58(4):448-458. PubMed ID: 31928102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma.
    Lanario JW; Hyland ME; Wei Y; Jones RC; Masoli M
    Respir Med; 2020 Feb; 162():105870. PubMed ID: 32056677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study.
    Cooper V; Metcalf L; Versnel J; Upton J; Walker S; Horne R
    NPJ Prim Care Respir Med; 2015 Jul; 25():15026. PubMed ID: 26158805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures to reduce maintenance therapy with oral corticosteroid in adults with severe asthma.
    Nguyen VQ; Ulrik CS
    Allergy Asthma Proc; 2016 Nov; 37(6):125-139. PubMed ID: 27931289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perception of oral corticosteroids in adult patients with asthma in France.
    Jaffuel D; Fabry-Vendrand C; Darnal E; Wilczynski O; Pain E; Bourdin A
    J Asthma; 2021 Jul; 58(7):946-957. PubMed ID: 32285714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid-dependent asthma in Sweden.
    Andersson M; Janson C; Kristensen T; Szende A; Golam S
    J Med Econ; 2020 Aug; 23(8):877-884. PubMed ID: 32324093
    [No Abstract]   [Full Text] [Related]  

  • 18. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature.
    Volmer T; Effenberger T; Trautner C; Buhl R
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30190274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational oral corticosteroid use in adult severe asthma: A narrative review.
    Chung LP; Upham JW; Bardin PG; Hew M
    Respirology; 2020 Feb; 25(2):161-172. PubMed ID: 31713955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing Oral Systemic Corticosteroids for Pediatric Asthma into EMS Treatment Guidelines: A Qualitative Study.
    McManus K; Cheetham A; Riney L; Brailsford J; Fishe JN
    Prehosp Emerg Care; 2023; 27(7):886-892. PubMed ID: 36125194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.